Enzalutamide

You have access
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET
Suzanne van der Gaag, André N. Vis, Imke H. Bartelink, Josephina C.C. Koppes, Marina Hodolic, Harry Hendrikse and Daniela E. Oprea-Lager

Journal of Nuclear Medicine March 1, 2025, 66 (3) 373-376; DOI: https://doi.org/10.2967/jnumed.124.268340
You have access
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors
Qaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen and Carlos Artigas

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1869-1875; DOI: https://doi.org/10.2967/jnumed.123.265874
You have access
Synthesis and Evaluation of ¹⁸F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-¹⁸F-Fluoro-5α-Dihydrotestosterone
Inês F. Antunes, Rutger J. Dost, Hilde D. Hoving, Aren van Waarde, Rudi A.J.O Dierckx, Douwe F. Samplonius, Wijnand Helfrich, Philip H. Elsinga, Erik F.J. de Vries and Igle J. de Jong

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1140-1145; DOI: https://doi.org/10.2967/jnumed.120.253641

Main menu